Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

INOVA UCC LLC

NPI: 1508592114 · VIENNA, VA 22180 · Urgent Care Clinic/Center · NPI assigned 07/26/2022

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official POPE, ALICE controls 11+ related entities in our dataset. Read more

$968K
Total Medicaid Paid
20,146
Total Claims
18,091
Beneficiaries
11
Codes Billed
2022-11
First Month
2024-12
Last Month

Provider Details

Authorized OfficialPOPE, ALICE (CFO)
Parent OrganizationINOVA HEALTHCARE SERVICES
NPI Enumeration Date07/26/2022

Related Entities

Other providers sharing the same authorized official: POPE, ALICE

ProviderCityStateTotal Paid
INOVA PHYSICIAN PARTNERS, LLC CHANTILLY VA $9.05M
INOVA HEALTH CARE SERVICES FAIRFAX VA $6.82M
INOVA HEALTH CARE SERVICES - PATHOLOGY FALLS CHURCH VA $2.00M
INOVA HEALTH CARE SERVICES VIENNA VA $1.82M
INOVA HEALTH CARE SERVICES DUMFRIES VA $648K
INOVA HEALTH CARE SERVICES FAIRFAX VA $339K
INOVA HEALTH CARE SERVICES FALLS CHURCH VA $303K
INOVA HEALTH CARE SERVICES FAIRFAX VA $239K
INOVA HEALTH CARE SERVICES WALDORF MD $207K
INOVA CARES - COMMUNITY FAIRFAX VA $45K
INOVA HEALTH CARE SERVICES FAIRFAX VA $0.16

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2022 854 $42K
2023 9,621 $451K
2024 9,671 $475K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 6,751 6,647 $504K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 3,392 3,281 $209K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 2,462 2,412 $82K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 3,373 1,672 $43K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 331 323 $36K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 2,546 2,501 $34K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 350 339 $30K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 651 631 $27K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 57 57 $3K
81003 221 216 $494.55
81025 12 12 $88.33